Clinical Trial Update: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TCD601 in inducing tolerance in kidney transplantation (PERSPECTIVE); the study, sponsored by ITB-Med LLC, is currently listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• TCD601

Snippet

Sponsor: ITB-Med LLC | Conditions: Kidney Transplantation | Phase 2 | Status: ACTIVE_NOT_RECRUITING